1215 Lee St, 
Charlottesville, VA 

Overview

William Petersen is a Pediatric Hematologist Oncology provider in Charlottesville, Virginia. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 23 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in VA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

1215 Lee St, Charlottesville, VA 22908
Other Locations
1204 W Main St, Charlottesville, VA 22903

Additional Areas of Focus

Dr. Petersen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


23 Clinical Trials

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Renal Tumors Classification, Biology, and Banking Study
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
View 21 Less Clinical Trials
Similar Doctors
Expertise in
2
conditions
Pediatric Hematology Oncology
Expertise in
2
conditions
Pediatric Hematology Oncology
1215 Lee St, 
Charlottesville, VA 
 (0.1 miles away)
Languages Spoken:
English
Offers Telehealth

Brian Belyea is a Pediatric Hematologist Oncology provider in Charlottesville, Virginia. Dr. Belyea is highly rated in 2 conditions, according to our data. His top areas of expertise are Rhabdomyosarcoma, Acute Lymphoblastic Leukemia (ALL), Adult Soft Tissue Sarcoma, Hemophagocytic Lymphohistiocytosis, and Tissue Biopsy.

Expertise in
1
conditions
Pediatric Hematology Oncology
Expertise in
1
conditions
Pediatric Hematology Oncology
1215 Lee St, 
Charlottesville, VA 
 (0.1 miles away)
Languages Spoken:
English
Offers Telehealth

Emily Moses is a Pediatric Hematologist Oncology provider in Charlottesville, Virginia. Dr. Moses is highly rated in 1 condition, according to our data. Her top areas of expertise are Optic Glioma, Glioma, Neuroblastoma, and Hereditary Neuroblastoma.

Expertise in
0
conditions
Pediatric Hematology Oncology
Expertise in
0
conditions
Pediatric Hematology Oncology
Lee St Fl 4, 
Charlottesville, VA 
 (1.2 miles away)
Languages Spoken:
English
Offers Telehealth

Colleen Druzgal is a Pediatric Hematologist Oncology provider in Charlottesville, Virginia. Her top areas of expertise are Hemophilia A, Hemophilia B, Hemophilic Arthropathy, and Acute Lymphoblastic Leukemia (ALL).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Petersen's expertise for a condition
ConditionClose
        View All 18 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile